Garnette D. Draper

Array ( [id] => 3919830 [patent_doc_number] => 05945097 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-31 [patent_title] => 'Method for lowering cholesterol levels with interleukin-10' [patent_app_type] => 1 [patent_app_number] => 8/924855 [patent_app_country] => US [patent_app_date] => 1997-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2956 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/945/05945097.pdf [firstpage_image] =>[orig_patent_app_number] => 924855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3996139 [patent_doc_number] => 05919905 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Cytokine designated LERK-6' [patent_app_type] => 1 [patent_app_number] => 8/920440 [patent_app_country] => US [patent_app_date] => 1997-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15095 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919905.pdf [firstpage_image] =>[orig_patent_app_number] => 920440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3764570 [patent_doc_number] => 05852176 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-22 [patent_title] => 'Antibodies to receptors for human interleukin-12' [patent_app_type] => 1 [patent_app_number] => 8/915495 [patent_app_country] => US [patent_app_date] => 1997-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10958 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/852/05852176.pdf [firstpage_image] =>[orig_patent_app_number] => 915495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3996107 [patent_doc_number] => 05919903 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Low affinity human IL-12 beta2 receptor' [patent_app_type] => 1 [patent_app_number] => 8/914520 [patent_app_country] => US [patent_app_date] => 1997-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15976 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919903.pdf [firstpage_image] =>[orig_patent_app_number] => 914520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3942763 [patent_doc_number] => 05998171 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'Polynucleotides encoding human endokine alpha' [patent_app_type] => 1 [patent_app_number] => 8/912227 [patent_app_country] => US [patent_app_date] => 1997-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 3 [patent_no_of_words] => 21921 [patent_no_of_claims] => 99 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/998/05998171.pdf [firstpage_image] =>[orig_patent_app_number] => 912227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4422128 [patent_doc_number] => 06177556 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-23 [patent_title] => 'Human SCF, a splice variant thereof, its pharmaceutical use' [patent_app_type] => 1 [patent_app_number] => 8/836252 [patent_app_country] => US [patent_app_date] => 1997-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 3456 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/177/06177556.pdf [firstpage_image] =>[orig_patent_app_number] => 836252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4209808 [patent_doc_number] => 06028176 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-22 [patent_title] => 'High-affinity interleukin-4 muteins' [patent_app_type] => 1 [patent_app_number] => 8/897020 [patent_app_country] => US [patent_app_date] => 1997-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12751 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/028/06028176.pdf [firstpage_image] =>[orig_patent_app_number] => 897020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3935697 [patent_doc_number] => 05981231 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Polynucleotides encoding chemokine .beta.-15' [patent_app_type] => 1 [patent_app_number] => 8/874460 [patent_app_country] => US [patent_app_date] => 1997-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 3 [patent_no_of_words] => 22957 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981231.pdf [firstpage_image] =>[orig_patent_app_number] => 874460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3998976 [patent_doc_number] => 05986059 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'T-cell selective interleukin-4 agonists' [patent_app_type] => 1 [patent_app_number] => 8/874697 [patent_app_country] => US [patent_app_date] => 1997-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 21 [patent_no_of_words] => 24296 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/986/05986059.pdf [firstpage_image] =>[orig_patent_app_number] => 874697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3996088 [patent_doc_number] => 05919902 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Leptin bound to inter-alphatrypsin inhibitor and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/870864 [patent_app_country] => US [patent_app_date] => 1997-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4090 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919902.pdf [firstpage_image] =>[orig_patent_app_number] => 870864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4144579 [patent_doc_number] => 06063600 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-16 [patent_title] => 'DNA encoding canine interleukin-1 receptor antagonist' [patent_app_type] => 1 [patent_app_number] => 8/862730 [patent_app_country] => US [patent_app_date] => 1997-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 7309 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/063/06063600.pdf [firstpage_image] =>[orig_patent_app_number] => 862730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4319930 [patent_doc_number] => 06248714 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-19 [patent_title] => 'Methods of inhibiting binding and treating Ig-mediated responses with IL-13 receptor' [patent_app_type] => 1 [patent_app_number] => 8/846340 [patent_app_country] => US [patent_app_date] => 1997-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11042 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/248/06248714.pdf [firstpage_image] =>[orig_patent_app_number] => 846340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4290264 [patent_doc_number] => 06268480 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'IL-13 Receptor chain' [patent_app_type] => 1 [patent_app_number] => 8/846344 [patent_app_country] => US [patent_app_date] => 1997-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11060 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/268/06268480.pdf [firstpage_image] =>[orig_patent_app_number] => 846344 [rel_patent_id] =>[rel_patent_doc_number] =>)